GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BiOptic Inc (ROCO:6850) » Definitions » Gross-Profit-to-Asset %

BiOptic (ROCO:6850) Gross-Profit-to-Asset % : 24.78% (As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BiOptic Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. BiOptic's annualized Gross Profit for the quarter that ended in Dec. 2024 was NT$145.7 Mil. BiOptic's average Total Assets over the quarter that ended in Dec. 2024 was NT$588.0 Mil. Therefore, BiOptic's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 was 24.78%.


BiOptic Gross-Profit-to-Asset % Historical Data

The historical data trend for BiOptic's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BiOptic Gross-Profit-to-Asset % Chart

BiOptic Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross-Profit-to-Asset %
Get a 7-Day Free Trial 29.34 31.08 32.45 26.91 20.70

BiOptic Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 38.55 24.29 27.89 17.57 24.78

Competitive Comparison of BiOptic's Gross-Profit-to-Asset %

For the Biotechnology subindustry, BiOptic's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BiOptic's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, BiOptic's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where BiOptic's Gross-Profit-to-Asset % falls into.


;
;

BiOptic Gross-Profit-to-Asset % Calculation

BiOptic's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Dec. 2024 )/( (Total Assets (A: Dec. 2023 )+Total Assets (A: Dec. 2024 ))/ count )
=125.28/( (613.773+596.409)/ 2 )
=125.28/605.091
=20.70 %

BiOptic's annualized Gross-Profit-to-Asset % for the quarter that ended in Dec. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Dec. 2024 )/( (Total Assets (Q: Jun. 2024 )+Total Assets (Q: Dec. 2024 ))/ count )
=145.696/( (579.64+596.409)/ 2 )
=145.696/588.0245
=24.78 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is two times the semi-annual (Dec. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


BiOptic Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of BiOptic's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


BiOptic Business Description

Traded in Other Exchanges
N/A
Address
No. 108-3, Minquan Road, 4th Floor, Xindian District, New Taipei, TWN, 23141
BiOptic Inc is a biotechnology instrumentation company that develops scientific products for research and clinical applications. It serves professionals and laboratories dedicated to life science research, clinical diagnostics, pharmaceutical and food industries, animal husbandry, and agriculture, performing diagnostic molecular genetic analyses.

BiOptic Headlines

No Headlines